MAPT and Alzheimer disease: While these radioligands can detect neuronal somatodendritic tau inclusions composed of all six isoforms observed in AD, in vivo detection of 3R tau isoforms has been challenging due to lower radioligand signal strength, off-target binding, or a lack of postmortem validation for non-AD aggregates [22, 23].